chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a physician refers to a patient of unknown demographics. Current conditions and medical history was not reproted. On an unknown date, the patient was vaccinated with VARIVAX (Merck), (dose, route, lot number and frequency were not reported). Concomitant medications were not reported. Reporting physician stated that many years ago, the patient developed chickenpox sometime after receiving VARIVAX (Merck). Outcome of the event was unknown. Causality assessment was not provided. This case is related to case number 1410USA016139 (same reporter). Additional information has been requested.
SUNDAY 06/27/2021: HEADACHES AND LETHARGY (ALL DAY) MONDAY 06/28/2021: HEADACHES (MORNING), LETHARGY AND MENTAL FOGGINESS (ALL DAY) TUESDAY 06/29/2021: LETHARGY AND MENTAL FOGGINESS (ALL DAY)
NERVE ISSUES SOMETHING SIMILAR TO GBS; POSSIBLE SMALL FIBER NEUROPATHY; MANY SIDE EFFECTS; LOST ABILITY TO PLAY GUITAR; BURNING IN FEET AND HANDS; NERVE PAIN COMES AND GO IN CYCLES; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced nerve issues something similar to gbs, possible small fiber neuropathy, many side effects, lost ability to play guitar, burning in feet and hands, and nerve pain comes and go in cycles. Laboratory data (dates unspecified) included: EMG (NR: not provided) no nerve damage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from burning in feet and hands, and the outcome of nerve issues something similar to gbs, possible small fiber neuropathy, many side effects, lost ability to play guitar and nerve pain comes and go in cycles was not reported. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case assessed as non-serious
First 2 days - Pain at injection site and arm. Around Day 6-7 - New pain and itching around injection site.   Days 8-10 - increased redness - about a 2-inch patch going down arm. Day 11-increased redness.  Some itching and a longer streak of redness. About 3 inches down arm. Day 12 - Woke up with larger, more defined area of redness and some itching.  About 4 1/2  inches long and 2 inches wide.  Called Occupational Health Clinic at CDC mid morning.  Recommended start Benadryl, Tylenol (500mg every 6 hrs) , and icing of the area.  OHC clinician will check back in the evening.
This spontaneous report was received from a physician referring to an 11 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was inadvertently vaccinated with GARDASIL 9 for prophylaxis (dose, route of administration, lot number and expiration date were not reported) and the vaccination with GARDASIL 9 was not intended to be administered to this patient. The reporter also denied any adverse effects reported by the patient.
This spontaneous report as received from a pharmacist via a company representative refers to a 65 year old male patient with coronary bypass. On an unknown date the patient was vaccinated with PNEUMOVAX23, injection (lot# and dose not reported). It was reported by the pharmacist who administered the vaccine that the patient at an unspecified time, complained of body aches and headache "shortly" after administration. No treatment was received. The pharmacist reported that the adverse symptoms resolved within 48 hours from time of administration. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Pt recvd vax 30OCT91 & approx 5 hrs p/immun, pt exp abdominal pain, vomiting & a fever of 104; hospitalized; treated w/oral ATB; blood cultures pending;
I got the booster on Dec. 30, 2021 at 10:50 a.m. Around 6:30 p.m. the next day, I had a sharp, shooting pain down my leg while passively standing. (I was not hinging, lifting, etc). I have "thrown my back out" approx. 3 times now, but the last time was about 18 months prior to this incident on 12/31/21. Also, the other two times, I was hinging or exercising. This seemingly happened completely untriggered. While I have not seen Dr. about this incident on 12/31/21, I have seen him ~18 months ago for the same. Dr. recommended I work on my core and I have been doing so pain-free in classes and private sessions 4x/week. This seemingly came out of nowhere, and I have read in an online thread that people who were doing fine with longer-term, chronic back issues had experienced "flare ups" after getting the booster, hence my report. It has been 1 week since my booster, and 6 days since I threw my back out, and I am still experiencing pain, however I know the kinds of stretches I need to do in order to heal based on past experience, thus I have not contacted Dr. I would be open to doing so, if necessary.
pt recvd vax 20JUL93 & devel fever & brief seizure taken to ER t016.2;
Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 05-FEB-2019, the patient was vaccinated with improperly stored GARDASIL 9 (1 injection, via intramuscular, lot #: N025428, expiration date: 19-JUN-2020; strength and anatomical location were not reported)for prophylaxis (Incorrect product storage)(product storage error). No adverse effect was reported. The GARDASIL 9 was exposed to 0 degree Celsius for 45 minutes. There was no previous temperature excursion. The data logger was involved. This is one of several reports received form the same reporter.  Sender's Comments: US-009507513-1903USA006922: US-009507513-1903USA006923: US-009507513-1903USA006924: US-009507513-1903USA006925: US-009507513-1903USA006926: US-009507513-1903USA006927: US-009507513-1903USA006928: US-009507513-1903USA006929: US-009507513-1903USA006930: US-009507513-1903USA006931: US-009507513-1903USA006932: US-009507513-1903USA006933: US-009507513-1903USA006934: US-009507513-1903USA006935: US-009507513-1903USA006936: US-009507513-1903USA006937: US-009507513-1903USA006938: US-009507513-1903USA006939: US-009507513-1903USA006940: US-009507513-1903USA006941: US-009507513-1903USA006942: US-009507513-1903USA006943: US-009507513-1903USA006944: US-009507513-1903USA006945: US-009507513-1903USA006946: US-009507513-1903USA006947: US-009507513-1903USA006948: US-009507513-1903USA006949: US-009507513-1903USA006950.
2yr p/vax (1995) devel chronic hepatitis B;liver showed cirrhotic changes w/abundant ascites poss decompensated chronic liver disease;pancreas hypoechoic & enlarged;poss pancreatitis;spleen enlarged;SOB;edema;atelectasis;anasarca, HTN
2 hours after receiving booster dose patient felt ill.  Family brought patient to ER the next day.  Patient has elevated white count sinus tachycardia shortness of breath and fever
Significant swelling in the arm that received two vaccinations, returned to normal after about 36 hours.
your covid vaccine can cause permanent headaches.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), outcome "not recovered", described as "your covid vaccine can cause permanent headaches.".  Additional information: Reported as, Patient took the shot over 9 months now and the headaches never went away. Patient lived in misery everyday since then.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever; Headache; Body aches; Dizziness; got the shot my arm is very sore there is a lump there its red its hot; got the shot my arm is very sore there is a lump there its red its hot; got the shot my arm is very sore there is a lump there its red its hot; got the shot my arm is very sore there is a lump there its red its hot; I'm not feeling good; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 27May2021 as 1st dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient got the shot, the first shot (unspecified shot) of the vaccine on Thursday (27May2021) and they said that patient had symptoms afterwards, first when he/she got it on Thursday, it was Thursday he/she do not know around may be 6'o clock or 7 somewhere around the very next day (28May2021), patient had started getting symptoms like fever, body aches, headache, dizziness. On an unspecified date of May2021, patient arm where he/she got the shot his/her arm was very sore there was a lump there its red its hot and was not feeling good. Patient stated that he/she was not going to start doing the survey when he/she was not feeling good. Patient still had a fever, arm where patient got the shot his/her arm was very sore there was a lump there it was red and its hot. Patient still had it and today was Monday, patient asked was that normal. The outcome of was not feeling good was unknown and not recovered for rest of the events.  Information about batch/ lot number has been requested.
G47.33 OBSTRUCTIVE SLEEP APNEA 5/4/2023 HX OF TRANSIENT ISCHEMIA ATTACK
COVID-19 Treatment; COVID-19 Treatment; Vaccine_brand=Pfizer / BioNTech;vaccine_brand_other=Moderna; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 64-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Dec2020 as dose 1, single (Batch/Lot number: unknown), on 13Jan2021 as dose 2, single (Batch/Lot number: unknown) and on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 63 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 18May2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa" (unspecified if ongoing), notes: Known allergies: sulfa; "Asthma" (unspecified if ongoing); "Depression" (unspecified if ongoing); "Breast cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 18May2022, outcome "unknown", described as "Vaccine_brand=Pfizer / BioNTech;vaccine_brand_other=Moderna"; VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID-19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 with Paxovid from 19Aug2022 to 23Aug2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: As there is limited information in the case provided, the causal association between the events vaccination failure, Covid-19 and interchange of vaccine products with the suspect product BNT162b2 cannot be excluded. The case will be reassessed once new information is available.
seizure/she passed out convulsing; headache; This is a spontaneous report from a contactable consumer (patient). A 20-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0176 and Expiration date: unknown), via an unknown route of administration, in left arm on 01Jun2021 at 12:25 (at the age of 20-years-old) as dose 1, single for covid-19 immunisation. The patient has no medical history. The patient's concomitant medications were not reported. She did various lab tests included drug panel test, test for diabetes, thyroid and MRI: results were not specified. On 01Jun2021, 2 minutes after receiving the vaccine, she got a bad reaction, so she mentioned that she got a seizure and she passed out convulsing and she would like to report this. She also had headache that lasted a while but when she woke up that was gone (improved). She had doctor visit afterwards, doctor recommended not to get the 2nd dose of the vaccine. She received treatment for events no other than Ibuprofen then no the dosage 2 of the 200 mg so 400 2 of them so 400. She wanted to know if the vaccination card needs to be signed off for the 2nd dose even if she is not eligible for it. Outcome of event seizure was unknown, and outcome of event headache was resolved on an unknown date in Jun2021.  Follow up (22Jun2021): This is a Follow up spontaneous report from a Pfizer sponsored program COVAX US support. A contactable 20-year-old female consumer (patient) reported events information.
Patient was given a booster too soon.  initial series was 7/29/21, 8/19/21. Booster given on 12/9/21.  Pfizer vaccine given all three times.
This spontaneous report was received from an 81 year old female patient reporting on herself with high blood pressure. Non drug reactions/allergies were reported. On 22-SEP-2012, the patient was vaccinated with ZOSTAVAX (concentration, dose, and lot number were not reported) for shingles. Concomitant therapies included Toprol. In October 2012, the patient began to break out in itchy hives all over her body. The hives went away and came back. It was reported that treatment was given with an unspecified ointment. None lab studies were performed. Patient sought medical attention by seeing a physician. The outcome of breaking out in itchy hives all over her body was reported as not recovered. Causality was not reported. This is one of two cases reported by the same source (MARRS # 1309USA014466). Additional information is not expected.
Information has been received from a consumer on 24-APR-2006 concerning his 12-month-old son with no pertinent medical history and no allergies, who was vaccinated in the leg with a dose of MMR II. Concomitant therapy included an "IPI vaccine". "Last Tuesday", on approximately 18-APR-2006, the patient experienced two seizures in one day, each lasted 4 minutes. One was at 01:00 am and the other was at 02:00 am. His son was taken to the emergency room but was not admitted to the hospital. A "bacterium cast" was performed, no results were reported. It was reported that after both seizures the child broke out with a rash on his body. At the time of this report the patient had recovered, it was reported that "he's doing okay now". No further information was reported. Upon internal review the patient's two seizures were determined to be other important medical events. Additional information is not expected.
Patient presented with along with 1 penny sized fluid filled blister with mini blisters around it on the upper left arm. Patient is not reporting having pain. Patient has been afebrile. Area is red and warm to touch. Reaction is not anywhere near where varicella injection was given was also given in the L arm.
5/25 vaccine; 5/27 menstrual cycle began; 5/28 much heavier menstrual bleeding, 5/29 mild epistaxis noted, sister sick with viral URI symptoms, 5/31 patient began to have cough, congestion, body aches; later noted bruising to right upper arm and right hip with no known trauma; 6/1 petechia to lower extremities; 6/2 started new oral contraceptive pack; 6/3 continue w/ menorrhagia & noticed many clots (very atypical, usually menstruation ceases at this point) 6/4 seen by PCR, CBC w/ platelet count 2,000, sent to hospital
Left upper arm pain, left shoulder pain, can not raise left arm to sideway (arm pain when raised to 45 degree). Diagnosed as shoulder adhesive capsulitis.
Headache, leg musle aches, fatigue  / all started at around 4 pm on 3/13 and. Ended about 9 pm on 3/14.
Typical side effects; Nightmares/bad night; Headaches; Chills; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Typical side effects), NIGHTMARE (Nightmares/bad night), HEADACHE (Headaches), CHILLS (Chills) and PYREXIA (slight fever) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 030M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to plants (The patient is allergic to plants (ragweed) and many trees.), Dust allergy (The patient is allergic to dust mites.), Allergy to feathers and Drug allergy (The patient is hypersensitive to certain medications, most recent an antifungal.). Concomitant products included LEVOTHYROXINE SODIUM (THYROXINE), LORATADINE (CLARITINE) and DOXYCYCLINE for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced VACCINATION COMPLICATION (Typical side effects), NIGHTMARE (Nightmares/bad night), HEADACHE (Headaches), CHILLS (Chills) and PYREXIA (slight fever). On 04-Mar-2021, NIGHTMARE (Nightmares/bad night), HEADACHE (Headaches) and CHILLS (Chills) had resolved. At the time of the report, VACCINATION COMPLICATION (Typical side effects) and PYREXIA (slight fever) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: This follow-up was received on 18-MAY-2021 which updated event( slight fever ).
Nausea, vomiting, fatigue, muscle aches, headache, chills unrelieved by over the counter medicine lasting over 3 days
Diffuse rash and urticaria about one hour after vaccine was given.  Treated with oral Benadryl and sent to emergency room.
Pt Lt upper arm was red and had blister. Pt was given oral antibiotic and Topical cream.
Patient was found unresponsive at home with SpO2 20% 1/2/2021
Shoulder to elbow-swollen, red, pain awaken at night from sleep. 8:00 AM next morning advised-cold compresses, elevate, TYLENOL (1st day nurse). 2 days later, Dr. visit to make sure it was in medical record. Pain lasted a week.
Four hours after the shot, I felt light-headed. After that, began  feeling warm, body aches, scratchy throat. Within a few hours, my throat was red, gums were red,  lips swollen and puffy. Complexion turned ruddy. I also developed very painful tongue ulcer(x2). Took and alternated Aleve and Tylenol. Slept for 2-3 hours. This onset, being the worst, lasted about 5 days, then the symptoms, less agressive, have never completely left.
had fevers, sweats, malaise for 3 days, then developed abdominal distension and hospitalized for small bowel obstruction
Large reaction (R) at injection site of varicella. Marked the reaction area with permanent marker and pt advised to watch for signs of injection 17cm x 9cm reaction. Recommended BENADRYL and ZYRTEC. RTC if worsens.
On August 6, 2020 at around 2p.m. I was getting up off my living room couch and both the bottoms of my feet as barefoot hurt terribly when walking across the living room floor. This included the skin hurting up in my arch which is higher somewhat than the floor when I press down. This condition lasted the same until about 3 weeks before my second Shingrix shot on October 6, 2020. The arch hurting in each foot when walking barefoot, lasted and was the last symptom to leave just 4 days before the second Shingrix shot.
he got Covid; he got Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 65-year-old male patient received BNT162b2 (BNT162B2), in Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, as dose 2, single (Batch/Lot number: unknown), in left arm and in Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), in Oct2022 as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "No" (unspecified if ongoing), notes: Other Conditions: No. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2022, outcome "unknown" and all described as "he got Covid".   Clinical course: I got the Prevnar 20 shot a week and a half ago on Saturday and two days later I found out I got Covid. I've had four of the Pfizer COVID-19 immunizations, the last being in Jul2022. How can the Covid infection affect the efficacy of Prevnar 20?" Got Prevnar 20 on 05Nov2022, started feeling poorly soon after, probably 07Nov2022 or 08Nov2022, didn't do a Covid test at first but is pretty sure caller had Covid the entire time, but did the test 13Nov2022 and tested positive but thinks caller had Covid starting the beginning of that week. Just thought caller was having a reaction to the Prevnar 20, like an immune response, at the beginning and started feeling like reaction was going on way too long, had a pretty bad sore throat, so tested and tested positive for Covid. Indication: Turned 65 in July and then coming and flu season and still Covid being around caller thought was a good idea to be vaccinated for pneumonia, standard thing. Confirmed all 4 doses were the Pfizer BioNTech COVID-19 vaccine. Lack of efficacy for the Pfizer BioNTech COVID-19 vaccine, got Prevnar 20 vaccine 05Nov2022 and 2 days later came down with Covid-19. Had 4 doses of the Pfizer BioNTech COVID-19 vaccine, with the most recent dose being in Jul2022. Calling more in regards to Prevnar 20 about efficacy of Prevnar 20 vaccine since contracted Covid after getting Prevnar 20. Had Covid also in Jan2022. Had Covid also in Jan2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 13Jan2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 04Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 04Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 20Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "thyroidectomy" (unspecified if ongoing), notes: other medical history: thyroidectomy; "Type 2 diabetes" (unspecified if ongoing), notes: recent diagnosis. Concomitant medication(s) included: OMEPRAZOLE; LEVOTHYROXINE; CRESTOR; METFORMIN. Past drug history included: Oxycodone, reaction(s): "known allergies: oxycodone", notes: known allergies: oxycodone; Tetracycline, reaction(s): "known allergies: tetracycline", notes: known allergies: tetracycline. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: Paxlovid for Treatment of COVID-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.